The Toxicology Forum is an international, nonprofit organization that is devoted to conducting open dialogues among various segments of society concerned with problems in toxicology.

At our meetings, views are exchanged among experts from domestic and international government regulatory and health agencies, industry, academia, 'political policymakers', and public interest groups. The Toxicology Forum aims to provide a scrupulously balanced approach to the topics and issues presented at The Forum, with alternative positions presented for each issue.

Next Meeting Details

37th Annual Winter Meeting of The Toxicology Forum
January 30-February 2, 2012 · , Washington, DC
Register Now

VIEW FULL AGENDA HERE

or copy and paste this into your browser

Full Agenda: http://www.cvent.com/events/37th-annual-winter-meeting-of-the-toxicology-forum/agenda-d4f36b510d7c47098857032f7acc3c0f.aspx

Keynote Address

Janet Woodcock, FDA, MD

Keynote Address

Peter Kim, Merck Research Laboratories, PA

SESSIONS:

  • Advancing Risk Assessment Approaches in the 21st Century
  • Recent Successes and Future Challenges in Accelerating Implementation of the NRC Tox 21 Report
  • Patient Risk Assessment Based on Carcinogenicity Evaluation of Pharmaceuticals 
  • Irradiation in the Production, Processing and Handling of Food: The U.S. Framework
  • Threshold of Toxicological Concern: Designs, Domains, and Databases
  • Improving our Understanding of the Cancer Risk Posed by Hexavalent Chromium in Drinking Water
  • When Epidemiology and Toxicology Collide: Navigating the Path Forward for Formaldehyde
  • Use of New Data on the Former Fuel Additive, MTBE,  in Hazard Identification and Risk Assessment

UPDATES:

  • NTP Workshop: Role of Environmental Chemicals in the Development of Diabetes and Obesity
  • FDA’s Guidance for Industry on Reproductive and Developmental Toxicities
  • The ELSIE Database: Extractable, Leachable and Knowledge Sharing Amongst  Pharmaceutical Companies and Regulators
  • FDA’s Dietary Supplements Office: New Director/New Directions
  • FDA’s Medical Countermeasures (MCM) Initiative: Responding Faster and More Effectively toBioterrorism and Infectious Diseases
  • A Therapeutic Intervention that Mitigates Intestinal Acute Radiation Poisoning
  • Protecting the U.S. Food Supply from Foods Contaminated with Radionuclides From a Nuclear Reactor Accident?